Bottom line
How much do IXJ and ETHSX overlap?
74% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 58.9% of IXJ's assets and 74.3% of ETHSX's. They are largely the same portfolio — owning both adds little diversification.
IXJ holds far more positions (124 vs 42), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IXJ and ETHSX have in common
| Holding | % of IXJ | % of ETHSX | Overlap |
|---|---|---|---|
| Eli Lilly And Company | 10.93% | 12.47% | 10.93% |
| Johnson & Johnson | 7.04% | 6.45% | 6.45% |
| Abbvie Inc. | 5.12% | 6.46% | 5.12% |
| Unitedhealth Group Incorporated | 4.40% | 5.49% | 4.40% |
| Merck & Co., Inc. | 4.12% | 5.08% | 4.12% |
| Astrazeneca Plc | 3.76% | 6.24% | 3.76% |
| Roche Holding AG | 3.75% | 5.44% | 3.75% |
| Novartis AG | 3.71% | 1.65% | 1.65% |
| Thermo Fisher Scientific Incorporated | 2.42% | 2.79% | 2.42% |
| Abbott Laboratories | 2.05% | 1.65% | 1.65% |
| Gilead Sciences, Inc. | 2.04% | 3.34% | 2.04% |
| Novo Nordisk A/s | 1.99% | 1.71% | 1.71% |
| Intuitive Surgical, Inc. | 1.83% | 2.72% | 1.83% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 3.38% | 1.64% |
| Bristol-myers Squibb Company | 1.53% | 4.25% | 1.53% |
| Stryker Corporation | 1.41% | 2.21% | 1.41% |
| Sanofi Sa | 1.18% | 2.95% | 1.18% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IXJ
- Amgen Inc. — 2.54%
- Pfizer Inc. — 1.78%
- Cvs Health Corporation — 1.71%
- Danaher Corporation — 1.56%
- Gsk Plc — 1.38%
- Medtronic Public Limited Company — 1.30%
- Mckesson Corporation — 1.18%
- Elevance Health, Inc. — 1.09%
Only in ETHSX
- Boston Scientific Corp — 2.18%
- Medtronic PLC — 1.80%
- Lonza Group AG — 1.77%
- Argenx SE — 1.61%
- Royalty Pharma PLC — 1.58%
- Neurocrine Biosciences Inc — 1.41%
- Mettler-Toledo International Inc — 1.36%
- Straumann Holding AG — 1.34%
Asset mix
| Asset type | IXJ | ETHSX |
|---|---|---|
| Stocks | 99.6% | 99.4% |
| Cash & short-term funds | 1.3% | 0.3% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | IXJ | ETHSX |
|---|---|---|
| US | 70.6% | 69.4% |
| CH | 10.4% | 10.2% |
| GB | 5.8% | 7.8% |
| JP | 3.7% | — |
| FR | 2.0% | 3.2% |
| DK | 2.3% | 2.9% |
| NL | 1.1% | 2.0% |
| IE | 1.6% | 1.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do IXJ and ETHSX overlap?
What stocks do IXJ and ETHSX have in common?
Should I own both IXJ and ETHSX?
Which holds more stocks, IXJ or ETHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.